nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CHRM3—nephrolithiasis	0.787	1	CbGaD
Maprotiline—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0945	CcSEcCtD
Maprotiline—Cutaneous vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00763	0.0759	CcSEcCtD
Maprotiline—CHRM3—ureter—nephrolithiasis	0.00722	0.438	CbGeAlD
Maprotiline—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.00355	0.0353	CcSEcCtD
Maprotiline—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0026	0.0259	CcSEcCtD
Maprotiline—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00254	0.0252	CcSEcCtD
Maprotiline—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0024	0.0239	CcSEcCtD
Maprotiline—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0023	0.0229	CcSEcCtD
Maprotiline—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0202	CcSEcCtD
Maprotiline—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00199	0.0198	CcSEcCtD
Maprotiline—Metixene—CHRM3—nephrolithiasis	0.00196	0.436	CrCbGaD
Maprotiline—CYP1A2—urine—nephrolithiasis	0.00178	0.108	CbGeAlD
Maprotiline—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00167	0.0166	CcSEcCtD
Maprotiline—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0161	CcSEcCtD
Maprotiline—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00159	0.0158	CcSEcCtD
Maprotiline—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00156	0.0155	CcSEcCtD
Maprotiline—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0154	CcSEcCtD
Maprotiline—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0153	CcSEcCtD
Maprotiline—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00153	0.0152	CcSEcCtD
Maprotiline—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0015	0.0149	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00143	0.0143	CcSEcCtD
Maprotiline—HTR2A—urine—nephrolithiasis	0.00139	0.0845	CbGeAlD
Maprotiline—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00136	0.0135	CcSEcCtD
Maprotiline—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0133	CcSEcCtD
Maprotiline—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00132	0.0131	CcSEcCtD
Maprotiline—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00131	0.013	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0013	0.013	CcSEcCtD
Maprotiline—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0127	CcSEcCtD
Maprotiline—CYP2D6—urine—nephrolithiasis	0.00127	0.077	CbGeAlD
Maprotiline—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00125	0.0124	CcSEcCtD
Maprotiline—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0115	CcSEcCtD
Maprotiline—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0114	CcSEcCtD
Maprotiline—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0113	CcSEcCtD
Maprotiline—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0113	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0011	0.011	CcSEcCtD
Maprotiline—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0109	CcSEcCtD
Maprotiline—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0109	CcSEcCtD
Maprotiline—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0109	CcSEcCtD
Maprotiline—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0108	CcSEcCtD
Maprotiline—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00104	0.0103	CcSEcCtD
Maprotiline—Nortriptyline—CHRM3—nephrolithiasis	0.001	0.224	CrCbGaD
Maprotiline—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.001	0.00995	CcSEcCtD
Maprotiline—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000995	0.0099	CcSEcCtD
Maprotiline—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000945	0.00941	CcSEcCtD
Maprotiline—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000932	0.00928	CcSEcCtD
Maprotiline—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000928	0.00923	CcSEcCtD
Maprotiline—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000893	0.00889	CcSEcCtD
Maprotiline—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00879	CcSEcCtD
Maprotiline—Tension—Hydrochlorothiazide—nephrolithiasis	0.000854	0.0085	CcSEcCtD
Maprotiline—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000852	0.00848	CcSEcCtD
Maprotiline—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000845	0.00841	CcSEcCtD
Maprotiline—Desipramine—CHRM3—nephrolithiasis	0.000827	0.184	CrCbGaD
Maprotiline—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00082	0.00816	CcSEcCtD
Maprotiline—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000815	0.00811	CcSEcCtD
Maprotiline—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0008	0.00796	CcSEcCtD
Maprotiline—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00078	0.00777	CcSEcCtD
Maprotiline—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000779	0.00775	CcSEcCtD
Maprotiline—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000769	0.00765	CcSEcCtD
Maprotiline—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000765	0.00761	CcSEcCtD
Maprotiline—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000738	0.00735	CcSEcCtD
Maprotiline—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000725	0.00721	CcSEcCtD
Maprotiline—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000716	0.00713	CcSEcCtD
Maprotiline—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00071	0.00707	CcSEcCtD
Maprotiline—Imipramine—CHRM3—nephrolithiasis	0.000702	0.156	CrCbGaD
Maprotiline—Shock—Hydrochlorothiazide—nephrolithiasis	0.000699	0.00695	CcSEcCtD
Maprotiline—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000695	0.00692	CcSEcCtD
Maprotiline—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000693	0.0069	CcSEcCtD
Maprotiline—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000687	0.00683	CcSEcCtD
Maprotiline—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000664	0.0066	CcSEcCtD
Maprotiline—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000642	0.00639	CcSEcCtD
Maprotiline—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000638	0.00635	CcSEcCtD
Maprotiline—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000631	0.00628	CcSEcCtD
Maprotiline—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00622	CcSEcCtD
Maprotiline—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000612	0.00609	CcSEcCtD
Maprotiline—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000607	0.00604	CcSEcCtD
Maprotiline—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000585	0.00582	CcSEcCtD
Maprotiline—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000581	0.00578	CcSEcCtD
Maprotiline—CHRM3—renal system—nephrolithiasis	0.000574	0.0348	CbGeAlD
Maprotiline—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000564	0.00562	CcSEcCtD
Maprotiline—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000561	0.00559	CcSEcCtD
Maprotiline—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000561	0.00559	CcSEcCtD
Maprotiline—CHRM3—kidney—nephrolithiasis	0.000555	0.0337	CbGeAlD
Maprotiline—HTR7—renal system—nephrolithiasis	0.000546	0.0332	CbGeAlD
Maprotiline—HTR7—kidney—nephrolithiasis	0.000528	0.0321	CbGeAlD
Maprotiline—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00051	0.00507	CcSEcCtD
Maprotiline—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000503	0.005	CcSEcCtD
Maprotiline—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000486	0.00484	CcSEcCtD
Maprotiline—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00047	0.00467	CcSEcCtD
Maprotiline—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000452	0.00449	CcSEcCtD
Maprotiline—Rash—Hydrochlorothiazide—nephrolithiasis	0.000448	0.00446	CcSEcCtD
Maprotiline—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000447	0.00445	CcSEcCtD
Maprotiline—Headache—Hydrochlorothiazide—nephrolithiasis	0.000445	0.00443	CcSEcCtD
Maprotiline—CYP1A2—renal system—nephrolithiasis	0.000436	0.0264	CbGeAlD
Maprotiline—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000422	0.0042	CcSEcCtD
Maprotiline—HTR2A—renal system—nephrolithiasis	0.000341	0.0207	CbGeAlD
Maprotiline—HTR2A—kidney—nephrolithiasis	0.000329	0.02	CbGeAlD
Maprotiline—CYP2D6—renal system—nephrolithiasis	0.00031	0.0188	CbGeAlD
Maprotiline—CYP2D6—kidney—nephrolithiasis	0.0003	0.0182	CbGeAlD
Maprotiline—HTR7—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000279	0.00304	CbGpPWpGaD
Maprotiline—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000275	0.00301	CbGpPWpGaD
Maprotiline—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000275	0.00301	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000275	0.003	CbGpPWpGaD
Maprotiline—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000272	0.00297	CbGpPWpGaD
Maprotiline—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000272	0.00297	CbGpPWpGaD
Maprotiline—HTR2C—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000266	0.0029	CbGpPWpGaD
Maprotiline—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000263	0.00287	CbGpPWpGaD
Maprotiline—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000252	0.00275	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000251	0.00274	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000251	0.00274	CbGpPWpGaD
Maprotiline—ABCB1—nephron tubule—nephrolithiasis	0.000246	0.0149	CbGeAlD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000239	0.00261	CbGpPWpGaD
Maprotiline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000238	0.00259	CbGpPWpGaD
Maprotiline—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000231	0.00252	CbGpPWpGaD
Maprotiline—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00023	0.00251	CbGpPWpGaD
Maprotiline—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00023	0.00251	CbGpPWpGaD
Maprotiline—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000227	0.00248	CbGpPWpGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000225	0.00246	CbGpPWpGaD
Maprotiline—ABCB1—renal system—nephrolithiasis	0.000223	0.0136	CbGeAlD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000216	0.00236	CbGpPWpGaD
Maprotiline—ABCB1—kidney—nephrolithiasis	0.000216	0.0131	CbGeAlD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000215	0.00235	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000215	0.00235	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—RGS14—nephrolithiasis	0.00021	0.0023	CbGpPWpGaD
Maprotiline—ABCB1—cortex of kidney—nephrolithiasis	0.00021	0.0128	CbGeAlD
Maprotiline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000206	0.00225	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000206	0.00225	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000205	0.00224	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000205	0.00224	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0002	0.00218	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0002	0.00218	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000199	0.00217	CbGpPWpGaD
Maprotiline—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000192	0.0021	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—RGS14—nephrolithiasis	0.000191	0.00209	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00019	0.00208	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00019	0.00208	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.00019	0.00208	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—CHRM3—nephrolithiasis	0.000182	0.00198	CbGpPWpGaD
Maprotiline—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000181	0.00198	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.00018	0.00197	CbGpPWpGaD
Maprotiline—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000178	0.00195	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000178	0.00194	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000178	0.00194	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000178	0.00194	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000177	0.00194	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000177	0.00193	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000177	0.00193	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000176	0.00192	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000175	0.00191	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000173	0.00189	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000172	0.00187	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—PTH—nephrolithiasis	0.000166	0.00182	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000164	0.00179	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000158	0.00172	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000158	0.00172	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000157	0.00171	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000155	0.0017	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000155	0.00169	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000153	0.00167	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000153	0.00167	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000153	0.00167	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000153	0.00166	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000152	0.00166	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.00015	0.00164	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00015	0.00164	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000142	0.00155	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—DGKH—nephrolithiasis	0.000142	0.00155	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000141	0.00154	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000137	0.00149	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000137	0.00149	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000135	0.00147	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000134	0.00147	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000134	0.00146	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000134	0.00146	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000134	0.00146	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000134	0.00146	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ADCY10—nephrolithiasis	0.000133	0.00145	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000132	0.00144	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—DGKH—nephrolithiasis	0.000129	0.00141	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.000129	0.0014	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000126	0.00138	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000125	0.00137	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000125	0.00136	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000125	0.00136	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000124	0.00136	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000123	0.00134	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000122	0.00134	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000122	0.00133	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.000122	0.00133	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000122	0.00133	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000121	0.00132	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.00012	0.00131	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.00012	0.00131	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000118	0.00129	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000117	0.00127	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000116	0.00127	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000116	0.00127	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000116	0.00126	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000114	0.00125	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RGS14—nephrolithiasis	0.000113	0.00123	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000108	0.00118	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000107	0.00116	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000106	0.00116	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000106	0.00116	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000106	0.00116	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000106	0.00115	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000105	0.00114	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000105	0.00114	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000103	0.00112	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000102	0.00111	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	9.79e-05	0.00107	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	9.7e-05	0.00106	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	9.52e-05	0.00104	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	9.46e-05	0.00103	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	9.46e-05	0.00103	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—PTH—nephrolithiasis	9.4e-05	0.00103	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—CHRM3—nephrolithiasis	9.33e-05	0.00102	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	9.29e-05	0.00101	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	9.25e-05	0.00101	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	9.1e-05	0.000993	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	9.08e-05	0.000991	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	9.05e-05	0.000988	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	9.02e-05	0.000985	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	8.93e-05	0.000975	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	8.88e-05	0.000969	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	8.81e-05	0.000962	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	8.8e-05	0.00096	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	8.8e-05	0.00096	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	8.64e-05	0.000943	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GRHPR—nephrolithiasis	8.57e-05	0.000935	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—PTH—nephrolithiasis	8.53e-05	0.000931	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	8.5e-05	0.000928	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	8.5e-05	0.000928	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	8.48e-05	0.000926	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	8.45e-05	0.000923	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	8.44e-05	0.000921	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	8.43e-05	0.00092	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	8.4e-05	0.000917	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	8.34e-05	0.000911	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	8.32e-05	0.000908	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	8.26e-05	0.000902	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	8.24e-05	0.0009	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	8.22e-05	0.000897	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	8.19e-05	0.000894	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	8.11e-05	0.000885	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	8.06e-05	0.00088	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	7.84e-05	0.000856	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	7.84e-05	0.000856	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	7.72e-05	0.000842	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AGXT—nephrolithiasis	7.64e-05	0.000834	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.62e-05	0.000832	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—DGKH—nephrolithiasis	7.62e-05	0.000832	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	7.58e-05	0.000827	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RGS14—nephrolithiasis	7.34e-05	0.000802	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	7.23e-05	0.000789	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RGS14—nephrolithiasis	7.21e-05	0.000787	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.2e-05	0.000786	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	7.2e-05	0.000786	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	7.19e-05	0.000784	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	7.16e-05	0.000782	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	7.09e-05	0.000774	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	6.93e-05	0.000756	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.9e-05	0.000753	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	6.9e-05	0.000753	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	6.88e-05	0.000751	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	6.69e-05	0.00073	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	6.58e-05	0.000718	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	6.56e-05	0.000716	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	6.54e-05	0.000714	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APRT—nephrolithiasis	6.49e-05	0.000709	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—SLC26A1—nephrolithiasis	6.49e-05	0.000709	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	6.46e-05	0.000705	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	6.29e-05	0.000687	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.27e-05	0.000684	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	6.11e-05	0.000667	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	6.07e-05	0.000663	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	6.02e-05	0.000657	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	6e-05	0.000655	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	5.98e-05	0.000653	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	5.97e-05	0.000652	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	5.97e-05	0.000651	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	5.96e-05	0.000651	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	5.94e-05	0.000648	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	5.91e-05	0.000645	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	5.87e-05	0.00064	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.62e-05	0.000613	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	5.62e-05	0.000613	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PTH—nephrolithiasis	5.55e-05	0.000606	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	5.51e-05	0.000602	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	5.46e-05	0.000596	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PTH—nephrolithiasis	5.45e-05	0.000595	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GRHPR—nephrolithiasis	5.44e-05	0.000593	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	5.43e-05	0.000593	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	5.42e-05	0.000591	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	5.36e-05	0.000585	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	5.21e-05	0.000568	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GRHPR—nephrolithiasis	5.12e-05	0.000559	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PTH—nephrolithiasis	5.04e-05	0.00055	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	4.99e-05	0.000544	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.96e-05	0.000541	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DGKH—nephrolithiasis	4.96e-05	0.000541	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	4.88e-05	0.000533	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.88e-05	0.000533	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DGKH—nephrolithiasis	4.87e-05	0.000532	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.87e-05	0.000532	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.85e-05	0.00053	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	4.85e-05	0.00053	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGXT—nephrolithiasis	4.85e-05	0.000529	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.84e-05	0.000528	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	4.84e-05	0.000528	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.79e-05	0.000523	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	4.79e-05	0.000523	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PTH—nephrolithiasis	4.76e-05	0.00052	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AQP1—nephrolithiasis	4.63e-05	0.000505	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGXT—nephrolithiasis	4.57e-05	0.000498	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PTH—nephrolithiasis	4.56e-05	0.000498	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GRHPR—nephrolithiasis	4.34e-05	0.000474	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APRT—nephrolithiasis	4.12e-05	0.00045	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SLC26A1—nephrolithiasis	4.12e-05	0.00045	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	4.06e-05	0.000444	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	3.88e-05	0.000424	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APRT—nephrolithiasis	3.88e-05	0.000424	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGXT—nephrolithiasis	3.87e-05	0.000422	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PTH—nephrolithiasis	3.72e-05	0.000406	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	3.59e-05	0.000391	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	3.53e-05	0.000385	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	3.52e-05	0.000384	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	3.51e-05	0.000383	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	3.46e-05	0.000378	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APRT—nephrolithiasis	3.29e-05	0.000359	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	3.29e-05	0.000359	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PTH—nephrolithiasis	3.28e-05	0.000358	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PTH—nephrolithiasis	3.23e-05	0.000352	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PTH—nephrolithiasis	3.22e-05	0.000352	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.21e-05	0.00035	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.2e-05	0.000349	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.17e-05	0.000346	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AQP1—nephrolithiasis	2.94e-05	0.00032	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AQP1—nephrolithiasis	2.77e-05	0.000302	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CHRM3—nephrolithiasis	2.66e-05	0.00029	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SPP1—nephrolithiasis	2.53e-05	0.000276	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CHRM3—nephrolithiasis	2.5e-05	0.000273	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	2.39e-05	0.000261	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AQP1—nephrolithiasis	2.34e-05	0.000256	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	2.29e-05	0.00025	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CHRM3—nephrolithiasis	2.12e-05	0.000231	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	1.87e-05	0.000204	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPP1—nephrolithiasis	1.65e-05	0.00018	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	1.62e-05	0.000177	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.62e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.61e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.61e-05	0.000175	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.59e-05	0.000174	CbGpPWpGaD
